At a glance
ClinicalIndex Comparison RecordN/ACompleted· 117 enrolled
Drug / intervention
Luminopia One +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Luminopia One Amblyopia Vision Improvement Study
In Brief
A clinical study evaluating Luminopia One and Refractive Correction for Amblyopia. Completed, enrolled 117 participants across 22 sites.
Detailed Summary
The objective of the study is to demonstrate the safety and efficacy of Luminopia One in amblyopia patients with amblyopia associated with anisometropia and/or with mild strabismus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmblyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartJan 2019
Primary CompletionJul 2020
TodayJul 2026
First PostedJul 31, 2018
Enrollment StartJan 16, 2019
Primary CompletionJul 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.9 years ago
Interventions
Luminopia Onedevice
Luminopia One is a virtual-reality based digital therapeutic that applies therapeutic modifications in real-time to cinematic content to rebalance visual input and treat amblyopia.
Refractive Correctiondevice
Standard of care refractive correction (ex. spectacles)